TMO Form 144: Insider to sell 10,225 shares, ~$5.84M value

Thermo Fisher Scientific (TMO) filed a Form 144 notice for a proposed sale of common stock by an affiliated holder.

Rhea-AI Filing Summary

Thermo Fisher Scientific (TMO) filed a Form 144 notice for a proposed sale of common stock by an affiliated holder. The filing lists 10,225 shares to be sold with an aggregate market value of $5,844,850.08, through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/07/2025.

The shares come from a mix of equity awards, including 8,475 shares from an option granted on 02/26/2019 (paid in cash on 11/07/2025) and multiple restricted stock vestings totaling 1,750 shares from 2021–2024. As context, shares outstanding were 375,708,059 at the time referenced in the notice; this is a baseline figure, not the amount being offered.

Insights

Equity capital markets analyst

Routine Form 144 for 10,225 TMO shares; neutral.

A TMO affiliate filed to sell 10,225 common shares, with an $5,844,850.08 aggregate market value. The plan lists execution via Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/07/2025. Form 144 is a notice allowing resales by affiliates under Rule 144.

The share sources include 8,475 option shares from a grant dated 02/26/2019 and 1,750 RSU shares vested between 2021 and 2024. Baseline context shows 375,708,059 shares outstanding. Actual market impact depends on execution and liquidity; no proceeds or use-of-proceeds details apply to the issuer here.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TMO disclose in this Form 144?

A proposed sale of 10,225 common shares with an aggregate market value of $5,844,850.08 by an affiliated holder.

When is the proposed sale date for TMO shares?

The notice lists an approximate sale date of 11/07/2025.

Which broker and exchange are named for the TMO sale?

Broker: Fidelity Brokerage Services LLC; Exchange: NYSE.

What is the source of the TMO shares to be sold?

From equity awards: 8,475 option shares (grant dated 02/26/2019) and 1,750 RSU shares vested in 2021–2024.

How many TMO shares were outstanding as context?

The filing shows 375,708,059 shares outstanding as a baseline figure.

Does Thermo Fisher receive proceeds from this Form 144 sale?

This is a resale by an affiliate under Rule 144; it concerns holder sales rather than issuer proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/07/2025 - 05:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001676320
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	THERMO FISHER SCIENTIFIC INC.
SEC File Number	001-08002
Address of Issuer	168 THIRD AVENUE WALTHAM MASSACHUSETTS 02451
Phone	7816221000
Name of Person for Whose Account the Securities are To Be Sold	Britt Lisa P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10225	5844850.08	375708059	11/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/07/2025	Option Granted - 02/26/2019	Issuer			8475	11/07/2025	Cash
Common	08/25/2021	Restricted Stock Vesting	Issuer			198	08/25/2021	Compensation
Common	08/27/2021	Restricted Stock Vesting	Issuer			300	08/27/2021	Compensation
Common	02/28/2023	Restricted Stock Vesting	Issuer			446	02/28/2023	Compensation
Common	08/23/2023	Restricted Stock Vesting	Issuer			163	08/23/2023	Compensation
Common	08/25/2023	Restricted Stock Vesting	Issuer			179	08/25/2023	Compensation
Common	08/28/2023	Restricted Stock Vesting	Issuer			72	08/28/2023	Compensation
Common	02/23/2024	Restricted Stock Vesting	Issuer			1	02/23/2024	Compensation
Common	02/28/2024	Restricted Stock Vesting	Issuer			1	02/28/2024	Compensation
Common	08/23/2024	Restricted Stock Vesting	Issuer			163	08/23/2024	Compensation
Common	08/25/2024	Restricted Stock Vesting	Issuer			62	08/25/2024	Compensation
Common	08/28/2024	Restricted Stock Vesting	Issuer			165	08/28/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lisa Britt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)